PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-0.12%
Negative net income growth while AVGO stands at 171.34%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.97%
Both reduce yoy D&A, with AVGO at -2.72%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
185.19%
Lower deferred tax growth vs. AVGO's 450.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
-3.23%
Both cut yoy SBC, with AVGO at -1.82%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
49.40%
Slight usage while AVGO is negative at -134.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
430.95%
AR growth while AVGO is negative at -1736.36%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-371.43%
Both reduce yoy inventory, with AVGO at -102.79%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
162.50%
Lower AP growth vs. AVGO's 326.09%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-82.87%
Negative yoy usage while AVGO is 256.60%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-517.39%
Both negative yoy, with AVGO at -210.71%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-8.03%
Negative yoy CFO while AVGO is 21.34%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-21.36%
Both yoy lines negative, with AVGO at -98.95%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
21.36%
Less M&A spending yoy vs. AVGO's 94.38%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
-33.10%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
15.29%
Liquidation growth of 15.29% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
68.13%
Growth of 68.13% while AVGO is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-28.20%
We reduce yoy invests while AVGO stands at 99.39%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
105.88%
Stock issuance far above AVGO's 15.15%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-4.18%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.